These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3274786)

  • 1. Compartmentalization and lymphocyte traffic after allograft challenge.
    Clemmings SM; Hoffman RA; Cahill DR; Simmons RL; Ascher NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):359-60. PubMed ID: 3274786
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of Th2-like T cells in regulating allograft reactivity against MHC class II-disparate antigen.
    Maeda H; Ogoshi S; Fujimoto S
    Transplant Proc; 1994 Apr; 26(2):847-8. PubMed ID: 8171685
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
    Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
    Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
    [No Abstract]   [Full Text] [Related]  

  • 4. T-cell recognition of donor class I major histocompatibility complex peptides during allograft rejection.
    Fangmann J; Dalchau R; Sawyer GJ; Priestley CA; Fabre JW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):187-8. PubMed ID: 8438268
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of tolerance induction by intrathymic injection of allogeneic cells.
    Hoffmann MW; Ruschmeyer D; Pichlmayr R
    Transplant Proc; 1995 Feb; 27(1):130-1. PubMed ID: 7878890
    [No Abstract]   [Full Text] [Related]  

  • 6. Peptide from one of the alpha helical regions of H-2Kb can manipulate responses to the H-2Kb alloantigen in vitro and in vivo.
    Wood K; Bell Y; Morris P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):481-2. PubMed ID: 8438387
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive effect of stepronin (TS-5010680) in mice.
    de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
    Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interaction of the lymph node and splenic lymphocytes of mice in inactivation of allogeneic hematopoietic stem cells].
    Dozmorov IM; Lutsenko GV; Nikolaeva IS; Petrov RV; Rudneva TB
    Biull Eksp Biol Med; 1985 May; 99(5):592-4. PubMed ID: 3890981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation.
    Woo J; Lu L; Fu F; Fung JJ; Qian S; Thomson AW
    Transplant Proc; 1995 Feb; 27(1):520-1. PubMed ID: 7879085
    [No Abstract]   [Full Text] [Related]  

  • 10. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue distribution of I region-associated antigens in the mouse.
    Hauptfeld V; Hauptfeld M; Klein J
    J Immunol; 1974 Jul; 113(1):181-8. PubMed ID: 4598886
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte recruitment properties of regional lymph node or spleen cells during skin allograft rejection.
    Hanto DW; Harty JT; Simmons RL
    Transplantation; 1983 Nov; 36(5):578-81. PubMed ID: 6356522
    [No Abstract]   [Full Text] [Related]  

  • 13. [Histology and cytology of the lymph nodes, spleen and thymus during allogeneic skin transplantation in mice].
    Lindner DP; Poberiĭ IA; Makhlin NV
    Arkh Patol; 1973; 35(6):19-25. PubMed ID: 4589015
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of intrathymic mixed chimerism for maintenance of skin allograft tolerance across fully allogeneic (entire major H-2 plus multiminor histocompatibility) antigen barriers in mice.
    Eto M; Nishimura Y; Kong YY; Maeda T; Nomoto K; Kumazawa J; Nomoto K
    Transplant Proc; 1994 Apr; 26(2):841-4. PubMed ID: 8171683
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice.
    Vossen AC; Tibbe GJ; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):380-2. PubMed ID: 7879028
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that a "four-cell cluster" may prime cytotoxic T-cells during graft rejection.
    Lee R; Glimcher LH; Auchincloss H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):847-9. PubMed ID: 8442245
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rejection mechanisms of allografts. Role of regional lymph nodes in the development of cytotoxic T lymphocytes].
    Mori K
    Fukuoka Igaku Zasshi; 1986 Feb; 77(2):87-97. PubMed ID: 3486809
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in peripheral V beta 11+ T-cell populations are not predictive of allograft rejection in I-E- mice resistant to neonatal tolerance induction.
    Nassiri M; Koh M; Padmanabhan J; Viciana A; Streilein JW; Ruiz P
    Transplant Proc; 1993 Feb; 25(1 Pt 1):368-70. PubMed ID: 8438339
    [No Abstract]   [Full Text] [Related]  

  • 20. T-reg mediated suppression of the allograft response in the draining lymph node.
    Lee MK; Moore DJ; Chiaccio M; Lian MM; Deng S; Mohiuddin M; Huang X; Koeberlein B; Zakheim A; Porrett PM; Barker CF; Caton AJ; Markmann JF
    Transplantation; 2006 Apr; 81(7):1063-6. PubMed ID: 16612285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.